Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
R Donghi, … , G Della Porta, M A Pierotti
R Donghi, … , G Della Porta, M A Pierotti
Published April 1, 1993
Citation Information: J Clin Invest. 1993;91(4):1753-1760. https://doi.org/10.1172/JCI116385.
View: Text | PDF
Research Article Article has an altmetric score of 13

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

  • Text
  • PDF
Abstract

The p53 gene was analyzed in tumor specimens obtained from 52 patients with various types of carcinoma of the thyroid gland by a combined molecular and immunocytochemical approach. The histologic types included 37 well-differentiated papillary and follicular carcinomas, 8 poorly differentiated, and 7 undifferentiated carcinomas. The p53 gene was shown to be unaffected in all differentiated tumors by single-strand conformation polymorphism analysis. However, in two out of eight (25%) of poorly differentiated carcinomas and five out of seven (71%) undifferentiated carcinomas, p53 mutations were identified and subsequently characterized by DNA sequencing. One undifferentiated carcinoma displayed two areas with varying degrees of differentiation. The comparative analysis of the p53 gene, in both the more and the less differentiated area of this tumor, clearly showed that the p53 mutation was confined to the latter component of the tumor specimen. These results indicate that mutations of the p53 gene are associated with the most aggressive histologic types of thyroid tumors, such as the undifferentiated carcinoma and, to a certain extent, the poorly differentiated carcinoma, and that the alterations of this gene represent a late genetic event in human thyroid carcinogenesis.

Authors

R Donghi, A Longoni, S Pilotti, P Michieli, G Della Porta, M A Pierotti

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1980 Total
Citations: 2 3 2 6 7 6 5 13 11 6 12 17 4 14 7 7 11 13 7 8 9 9 11 10 13 8 12 8 14 6 9 1 271
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (271)

Title and authors Publication Year
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation
Lee M, Morris LG
Oncotarget 2024
Risk stratification for radioactive iodine refractoriness using molecular alterations in distant metastatic differentiated thyroid cancer
Mu Z, Zhang X, Liang D, Fang J, Chen G, Guo W, Sun D, Sun Y, Kai Z, Huang L, Liang J, Lin Y
Chinese Journal of Cancer Research 2024
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells.
Veschi V, Turdo A, Modica C, Verona F, Di Franco S, Gaggianesi M, Tirrò E, Di Bella S, Iacono ML, Pantina VD, Porcelli G, Mangiapane LR, Bianca P, Rizzo A, Sciacca E, Pillitteri I, Vella V, Belfiore A, Bongiorno MR, Pistone G, Memeo L, Colarossi L, Giuffrida D, Colarossi C, Vigneri P, Todaro M, Stassi G
Nature Communications 2023
Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer.
de Mello DC, Saito KC, Cristovão MM, Kimura ET, Fuziwara CS
International journal of molecular sciences 2023
Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study.
Razia S, Nakayama K, Yamashita H, Ishibashi T, Ishikawa M, Kanno K, Sato S, Kyo S
Current oncology (Toronto, Ont.) 2023
Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View
Rajabi S, Alix-Panabières C, Alaei AS, Abooshahab R, Shakib H, Ashrafi MR
Cancers 2022
Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas.
De Martino M, Esposito F, Capone M, Pallante P, Fusco A
Cancers 2022
A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer
C Romei, R Elisei
International journal of molecular sciences 2021
Cancer Stemness: p53 at the Wheel
D Ghatak, DD Ghosh, S Roychoudhury
Frontiers in Oncology 2021
Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy
J Hu, IJ Yuan, S Mirshahidi, A Simental, SC Lee, X Yuan
International journal of molecular sciences 2021
The Emerging Landscapes of Long Noncoding RNA in Thyroid Carcinoma: Biological Functions and Clinical Significance
J Zhu, C Liu, D Wang, X Cao, S Wang, Y Liu, J Wang, P Li, Q He
Frontiers in Oncology 2021
The Knockdown of Nrf2 Suppressed Tumor Growth and Increased the Sensitivity to Lenvatinib in Anaplastic Thyroid Cancer
Z Gong, L Xue, M Wei, Z Liu, AC Vlantis, CA van Hasselt, JY Chan, D Li, X Zeng, MC Tong, GG Chen, S Bekeschus
Oxidative Medicine & Cellular Longevity 2021
MI‑773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1
YL Chen, ZM Zhang, XL Li, YF Tao, SY Wu, F Fang, Y Xie, XM Liao, Li, D Wu, HR Wang, R Zuo, HB Cao, JJ Pan, JJ Yu, Z Zhang, XR Chu, YP Zhang, CX Feng, JW Wang, J Lu, SY Hu, ZH Li, J Pan
Oncology Letters 2021
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies
M Saqcena, LJ Leandro-Garcia, JL Maag, V Tchekmedyian, GP Krishnamoorthy, PP Tamarapu, V Tiedje, V Reuter, JA Knauf, E de Stanchina, B Xu, XH Liao, S Refetoff, R Ghossein, P Chi, AL Ho, RP Koche, JA Fagin
Cancer Discovery 2020
Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma
B Xu, T Qin, J Yu, TJ Giordano, MA Sartor, RJ Koenig
The Journal of biological chemistry 2020
New Therapies for Advanced Thyroid Cancer
D Laha, N Nilubol, M Boufraqech
Frontiers in Endocrinology 2020
The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity
S Pellecchia, R Sepe, M Decaussin-Petrucci, C Ivan, M Shimizu, C Coppola, D Testa, GA Calin, A Fusco, P Pallante
Cancers 2020
Primary squamous cell carcinoma of thyroid with a novel BRAF mutation and High PDL-1 expression: A case report with treatment implications and review of literature
M Torrez, RC Braunberger, E Yilmaz, S Agarwal
Pathology, research and practice 2020
Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis
H Tabatabaeian, SP Yang, Y Tay
Cancers 2020
Exploiting GRK2 Inhibition as a Therapeutic Option in Experimental Cancer Treatment: Role of p53-Induced Mitochondrial Apoptosis
J Gambardella, A Fiordelisi, G Santulli, M Ciccarelli, FA Cerasuolo, M Sala, E Sommella, P Campiglia, M Illario, G Iaccarino, D Sorriento
Cancers 2020
Genetic-guided Risk Assessment and Management of Thyroid Cancer
M Xing
Endocrinology and metabolism clinics of North America 2019
The Thyroid and Its Diseases: A Comprehensive Guide for the Clinician
M Luster, LH Duntas, L Wartofsky
2019
Genetic alterations in anaplastic thyroid carcinoma
M Rashid, A Agarwal, R Pradhan, N George, N Kumari, M Sabaretnam, G Chand, A Mishra, G Agarwal, SK Mishra
Indian journal of endocrinology and metabolism 2019
METTL7B promotes migration and invasion in thyroid cancer through epithelial-mesenchymal transition
D Ye, Y Jiang, Y Sun, Y Li, Y Cai, Q Wang, O Wang, E Chen, X Zhang
Journal of Molecular Endocrinology 2019
The significance of gene mutations across eight major cancer types
P Paul, AK Malakar, S Chakraborty
Mutation Research/Reviews in Mutation Research 2019
Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma
Z Gao, T Lu, H Song, Z Gao, F Ren, P Ouyang, Y Wang, J Zhu, S Zhou, X He
Medical science monitor : international medical journal of experimental and clinical research 2019
Coding Molecular Determinants of Thyroid Cancer Development and Progression
V Valvo, C Nucera
Endocrinology and metabolism clinics of North America 2018
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
C Romei, A Tacito, E Molinaro, P Piaggi, V Cappagli, L Pieruzzi, A Matrone, D Viola, L Agate, L Torregrossa, C Ugolini, F Basolo, LD Napoli, M Curcio, R Ciampi, G Materazzi, P Vitti, R Elisei
Oncology Letters 2018
Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway
H Zhang, N Hu
Molecular medicine reports 2018
Genetic aberrations and alterations in signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer
S Saini, AV Maker, KD Burman, BS Prabhakar
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018
A Review of Driver Genetic Alterations in Thyroid Cancers
Fatemeh Khatami, Seyed Mohammad Tavangar
Iranian Journal of Pathology 2018
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
E Molinaro, C Romei, A Biagini, E Sabini, L Agate, S Mazzeo, G Materazzi, S Sellari-Franceschini, A Ribechini, L Torregrossa, F Basolo, P Vitti, R Elisei
Nature Reviews Endocrinology 2017
ZCCHC12, a novel oncogene in papillary thyroid cancer
O Wang, Z Zheng, Q Wang, Y Jin, W Jin, Y Wang, E Chen, X Zhang
Journal of Cancer Research and Clinical Oncology 2017
Diagnostic Molecular Pathology
RC Arcenas
Diagnostic Molecular Pathology 2017
Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases
B Bonhomme, Y Godbert, G Perot, AA Ghuzlan, S Bardet, G Belleannée, L Crinière, CD Cao, G Fouilloux, S Guyetant, A Kelly, S Leboulleux, C Buffet, E Leteurtre, JJ Michels, F Tissier, ME Toubert, M Wassef, C Pinard, I Hostein, I Soubeyran
Thyroid 2017
Oncogenesis of Thyroid Cancer
Enas Younis
Asian Pacific Journal of Cancer Prevention 2017
Thyroid and Parathyroid Ultrasound and Ultrasound-Guided FNA
DS Duick, RA Levine, MA Lupo
Thyroid and Parathyroid Ultrasound and Ultrasound-Guided FNA 2017
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
G Acquaviva, M Visani, A Repaci, KJ Rhoden, D Biase, A Pession, T Giovanni
Histopathology 2017
Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis
YS Song, CK Jung, KC Jung, YJ Park, JK Won
Journal of Korean Medical Science 2017
Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies
NA Cipriani, S Agarwal, D Dias-Santagata, WC Faquin, PM Sadow
Thyroid 2017
The interplay between histone deacetylases and rho kinases is important for cancer and neurodegeneration
S Mertsch, OH Krämer
Cytokine & Growth Factor Reviews 2017
Glycolysis-related protein expression in thyroid cancer
JH Nahm, HM Kim, JS Koo
Tumor Biology 2017
New perspectives in the diagnosis of thyroid follicular lesions
E Baldini, S Sorrenti, F Tartaglia, A Catania, A Palmieri, D Pironi, A Filippini, S Ulisse
International journal of surgery (London, England) 2017
Gene master regulators of papillary and anaplastic thyroid cancers
DA Iacobas, NY Tuli, S Iacobas, JK Rasamny, A Moscatello, J Geliebter, RK Tiwari
Oncotarget 2017
Genomic and Transcriptomic Hallmarks of Poorly-Differentiated and Anaplastic Thyroid Cancers
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A. Knauf, Ronak Shah, Snjezana Dogan, Julio Ricarte-Filho, Gnana P. Krishnamoorthy, Bin Xu, Nikolaus Schultz, Michael Berger, Chris Sander, Barry Taylor, Ronald Ghossein, Ian Ganly, James Fagin
Journal of Clinical Investigation 2016
Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer
S Narayanan, AD Colevas
Current Treatment Options in Oncology 2016
Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation
Y Shetzer, A Molchadsky, V Rotter
Cold Spring Harbor Perspectives in Medicine 2016
Expression of glutamine metabolism-related proteins in thyroid cancer
HM Kim, YK Lee, JS Koo
Oncotarget 2016
Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer
S Latteyer, V Tiedje, K König, S Ting, LC Heukamp, L Meder, KW Schmid, D Führer, LC Moeller
Endocrine 2016
Molecular genetics of thyroid cancer
M Rebaї, A Rebaї
Genetics Research 2016
Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer
L Zhang, M Boufraqech, R Lake, E Kebebew
Oncotarget 2016
Nodular thyroid disease in the elderly: novel molecular approaches for the diagnosis of malignancy
S Sorrenti, E Baldini, F Tartaglia, A Catania, S Arcieri, D Pironi, PG Calò, A Filippini, S Ulisse
Aging clinical and experimental research 2016
Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer
S Latteyer, V Tiedje, K König, S Ting, LC Heukamp, L Meder, KW Schmid, D Führer, LC Moeller
Endocrine 2016
Next-generation sequence detects ARAP3 as a novel oncogene in papillary thyroid carcinoma
QX Wang, ED Chen, YF Cai, YL Zhou, ZC Zheng, YH Wang, YX Jin, WX Jin, XH Zhang, OC Wang
OncoTargets and therapy 2016
Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma
J Lu, S Guan, Y Zhao, Y Yu, Y Wang, Y Shi, X Mao, KL Yang, W Sun, X Xu, JS Yi, T Yang, J Yang, JG Nuchtern
Oncotarget 2016
Follicular cell-derived thyroid cancer
H Dralle, A Machens, J Basa, V Fatourechi, S Franceschi, ID Hay, YE Nikiforov, F Pacini, JL Pasieka, SI Sherman
Nature Reviews Disease Primers 2015
SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways.
Grassi ES, Vezzoli V, Negri I, Lábadi Á, Fugazzola L, Vitale G, Persani L
Oncotarget 2015
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer
Zhang L, Zhang Y, Mehta A, Boufraqech M, Davis S, Wang J, Tian Z, Yu Z, Boxer MB, Kiefer JA, Copland JA, Smallridge RC, Li Z, Shen M, Kebebew E
Oncotarget 2015
Mutations of TSHR and TP53 Genes in an Aggressive Clear Cell Follicular Carcinoma of the Thyroid
GX Tong, K Mody, Z Wang, D Hamele-Bena, MN Nikiforova, YE Nikiforov
Endocrine Pathology 2015
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer
Lisa Zhang, Yaqin Zhang, Amit Mehta, Myriem Boufraqech, Sean Davis, Jing Wang, Ze Tian, Zhiya Yu, Matthew B Boxer, Jeffrey A Kiefer, John A Copland, Robert C Smallridge, Zhuyin Li, Min Shen, Electron Kebebew
Oncotarget 2015
Zn(II)-curc targets p53 in thyroid cancer cells
A Garufi, V D'Orazi, A Crispini, G D'Orazi
International journal of oncology 2015
Molecular approaches to thyroid cancer diagnosis
SJ Hsiao, Y Nikiforov
Endocrine Related Cancer 2014
Immunohistochemical Expression of Potential Therapeutic Targets in Canine Thyroid Carcinoma
M Campos, R Ducatelle, HS Kooistra, G Rutteman, L Duchateau, I Polis, S Daminet
Journal of Veterinary Internal Medicine 2014
Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71
R Parenti, L Salvatorelli, G Magro
International Journal of Endocrinology 2014
Pax-8–PPAR-γ fusion protein in thyroid carcinoma
P Raman, RJ Koenig
Nature Reviews Endocrinology 2014
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
CS Fuziwara, ET Kimura
International Journal of Endocrinology 2014
The paradigm of mutant p53-expressing cancer stem cells and drug resistance
Y Shetzer, H Solomon, G Koifman, A Molchadsky, S Horesh, V Rotter
Carcinogenesis 2014
An update on molecular biology of thyroid cancers
O Omur, Y Baran
Critical Reviews in Oncology/Hematology 2014
p53: The barrier to cancer stem cell formation
R Aloni-Grinstein, Y Shetzer, T Kaufman, V Rotter
FEBS Letters 2014
Association of P53 (−16ins-Pro) Haplotype with the Decreased Risk of Differentiated Thyroid Carcinoma in Iranian-Azeri Patients
R Dehghan, MA Feizi, N Pouladi, E Babaei, V Montazeri, A Fakhrjoo, A Sedaei, P Azarfam, M Nemati
Pathology & Oncology Research 2014
Targeting RAS/MAPK/ERK and PI3K/AKT/mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma
Z Milosevic, M Pesic, T Stankovic, J Dinic, Z Milovanovic, J Stojsic, R Dzodic, N Tanic, J Bankovic
Translational Research 2014
Imaging, genetic testing, and biomarker assessment of follicular cell-derived thyroid cancer
HH Patel, N Goyal, D Goldenberg
Annals of Medicine 2014
Is Poorly Differentiated Thyroid Cancer Poorly Characterized?
KD Burman
The Journal of clinical endocrinology and metabolism 2014
Tumour suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis.
Angelo Ferraro, Filippo Schepis, vincenza leone, Antonella Federico, Eleonora Borbone, Pierlorenzo Pallante, Maria Teresa Berlingieri, Gennaro Chiapetta, Mario Monaco, Claudio Arra, Giuseppe Palma, Dario Palmieri, Giancarlo Troncone, Lorenzo Chiariotti, Massimo Santoro, Alfredo Fusco
2013
Molecular pathogenesis and mechanisms of thyroid cancer
M Xing
Nature Reviews Cancer 2013
Genetics and epigenetics of sporadic thyroid cancer
D Vu-Phan, RJ Koenig
Molecular and Cellular Endocrinology 2013
Deregulation of microRNA expression in thyroid neoplasias
P Pallante, S Battista, GM Pierantoni, A Fusco
Nature Reviews Endocrinology 2013
Progress in molecular-based management of differentiated thyroid cancer
M Xing, BR Haugen, M Schlumberger
The Lancet 2013
eLS
YC Chang, YH Yu, LM Chuang
Encyclopedia of Life Sciences 2013
Therapeutic strategies in the management of patients with metastatic anaplastic thyroid cancer: review of the current literature
R Granata, L Locati, L Licitra
Current Opinion in Oncology 2013
Genetic mutations, molecular markers and future directions in research
KN Patel
Oral Oncology 2013
Recent progress of genome study for anaplastic thyroid cancer
J Lee, JA Hwang, EK Lee
Genomics & Informatics 2013
Essential genes in thyroid cancers: focus on fascin
H Samimi, MZ Dizaji, M Ghadami, AS Fazeli, P Khashayar, M Soleimani, B Larijani, V Haghpanah
Journal of Diabetes & Metabolic Disorders 2013
The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells
F Guerrieri, S Piconese, C Lacoste, V Schinzari, B Testoni, Y Valogne, S Gerbal-Chaloin, D Samuel, C Bréchot, J Faivre, M Levrero
Cell Death and Disease 2013
p53 antibody: is it an indicator of dedifferentiated thyroid cancer?
Z Hasbek, B Turgut, T Erselcan
Annals of Nuclear Medicine 2013
Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
MN Nikiforova, AI Wald, S Roy, MB Durso, YE Nikiforov
The Journal of clinical endocrinology and metabolism 2013
Prognostic value of epidermal growth factor receptor, p53 and galectin-3 expression in papillary thyroid carcinoma
YM Lee, JB Lee
J INT MED RES 2013
Molecular Pathology and Diagnostics of Cancer
D Coppola
2013
Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review
A Guerra, VD Crescenzo, A Garzi, M Cinelli, C Carlomagno, M Tonacchera, P Zeppa, M Vitale
BMC surgery 2013
Nodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literature
VD Crescenzo, A Garzi, F Petruzziello, M Cinelli, L Catalano, P Zeppa, M Vitale
BMC surgery 2013
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma
Vladimir Ratushny, Michael Gober, Ryan Hick, Todd Ridky, John Seykora
Journal of Clinical Investigation 2012
Poorly Differentiated Thyroid Carcinoma: An Incubating Entity
PM Sadow, WC Faquin
Frontiers in Endocrinology 2012
Inflammation in thyroid oncogenesis
F Liotti, C Visciano, RM Melillo
American journal of cancer research 2012
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
RC Smallridge, KB Ain, SL Asa, KC Bible, JD Brierley, KD Burman, E Kebebew, NY Lee, YE Nikiforov, MS Rosenthal, MH Shah, AR Shaha, RM Ass
Thyroid 2012
Recent advances in molecular diagnosis of thyroid cancer
I Legakis, K Syrigos
Journal of Thyroid Research 2011
Molecular genetics and diagnosis of thyroid cancer
YE Nikiforov, MN Nikiforova
Nature Reviews Endocrinology 2011
The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas
L Lavra, C Rinaldo, A Ulivieri, E Luciani, P Fidanza, L Giacomelli, C Bellotti, A Ricci, M Trovato, S Soddu, A Bartolazzi, S Sciacchitano
PloS one 2011
BRAF, p53 and SOX2 in anaplastic thyroid carcinoma
G Gauchotte, C Philippe, S Lacomme, B Léotard, MP Wissler, L Allou, B Toussaint, M Klein, JM Vignaud, A Bressenot
Pathology 2011
Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma
JH Chen, WC Faquin, RV Lloyd, V Nosé
Modern Pathology 2011
Abnormal Nuclear Structures (Micronuclei, Nuclear Blebs, Strings, and Pockets) in a Case of Anaplastic Giant Cell Carcinoma of the Thyroid: An Immunohistochemical and Ultrastructural Study
RA Caruso, F Fedele, C Crisafulli, D Paparo, A Parisi, R Lucianò, V Cavallari
Ultrastructural Pathology 2011
Thyroid Cancer
J Machac
Thyroid Cancer 2011
Well differentiated follicular thyroid neoplasia: Impact of molecular and technological advances on detection, monitoring and treatment
AG Gianoukakis, SM Giannelli, WA Salameh, LW McPhaul
Molecular and Cellular Endocrinology 2011
Poorly differentiated thyroid carcinoma in a 9-year-old boy: case report
YL Wu, WH Ting, SL Wey, CK Chen, CY Huang, SP Cheng, YJ Lee
Journal of Pediatric Endocrinology and Metabolism 2011
Gene expression profile of human thyroid cancer in relation to its mutational status
D Rusinek, S Szpak-Ulczok, B Jarzab
Journal of Molecular Endocrinology 2011
Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
P Soares, J Lima, A Preto, P Castro, J Vinagre, R Celestino, JP Couto, H Prazeres, C Eloy, V Máximo, M Sobrinho-Simões
Current genomics 2011
Cytologic and molecular diagnosis of thyroid cancers : Is it time for routine reflex testing?
LA Hassell, EM Gillies, ST Dunn
Cancer Cytopathology 2011
Poorly differentiated thyroid carcinoma: an evolving entity
G Garcia-Rostan, M Sobrinho-Simões
Diagnostic Histopathology 2011
The Loss of the p53 Activator HIPK2 Is Responsible for Galectin-3 Overexpression in Well Differentiated Thyroid Carcinomas
L Lavra, C Rinaldo, A Ulivieri, E Luciani, P Fidanza, L Giacomelli, C Bellotti, A Ricci, M Trovato, S Soddu, A Bartolazzi, S Sciacchitano, HT Nguyen
PloS one 2011
Thyroid cancer: current molecular perspectives
F Giusti, A Falchetti, F Franceschelli, F Marini, A Tanini, ML Brandi
Journal of Oncology 2010
A Practical Manual of Thyroid and Parathyroid Disease
KN Patel, B Singh
A Practical Manual of Thyroid and Parathyroid Disease 2010
Changes of Apoptosis, p53, and bcl-2 by Irradiation in Poorly Differentiated Thyroid Carcinoma Cell Lines: A Prognostic Marker for the Prospect of Therapeutic Success?
F Pohl, J Grosse, D Grimm, G Brockhoff, K Westphal, J Moosbauer, O Koelbl, M Infanger, C Eilles, J Schoenberger
Thyroid 2010
Thyroid cancer and inflammation
V Guarino, MD Castellone, E Avilla, RM Melillo
Molecular and Cellular Endocrinology 2010
Medullary, Anaplastic, and Metastatic Cancers of the Thyroid
SC Pitt, JF Moley
Seminars in Oncology 2010
Molecular pathogenesis of follicular cell derived thyroid cancers
R Parameswaran, S Brooks, GP Sadler
International Journal of Surgery 2010
Molecular and Other Novel Advances in Treatment of Metastatic Epithelial and Medullary Thyroid Cancers
D Tai, D Poon
Journal of Oncology 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Poorly Differentiated Thyroid Carcinoma: 5 Years after the 2004 WHO Classification of Endocrine Tumours
M Volante, M Papotti
Endocrine Pathology 2009
Thyroid tumors: novel insights from proteomic studies
G Damante, A Scaloni, G Tell
Expert Review of Proteomics 2009
Thyroid Papillary Carcinoma with Micropapillary and Hobnail Growth Pattern: A Histological Variant with Intermediate Malignancy?
U Motosugi, SI Murata, K Nagata, M Yasuda, M Shimizu
Thyroid 2009
Poorly Differentiated Thyroid Carcinoma
M Bongiovanni, PM Sadow, WC Faquin
Advances in Anatomic Pathology 2009
RAS Mutations Are the Predominant Molecular Alteration in Poorly Differentiated Thyroid Carcinomas and Bear Prognostic Impact
M Volante, I Rapa, M Gandhi, G Bussolati, D Giachino, M Papotti, YE Nikiforov
The Journal of clinical endocrinology and metabolism 2009
Endocrine Pathology:
RV Lloyd
2009
Molecular pathology of thyroid cancer: diagnostic and clinical implications
JA Fagin, N Mitsiades
Best Practice & Research Clinical Endocrinology & Metabolism 2008
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
RC Smallridge, LA Marlow, JA Copland
Endocrine Related Cancer 2008
Poorly Differentiated Thyroid Carcinoma: Diagnostic Features and Controversial Issues
M Volante, I Rapa, M Papotti
Endocrine Pathology 2008
Clinical Significance of P53 Protein Expression in Papillary Thyroid Carcinoma
N Morita, Y Ikeda, H Takami
World Journal of Surgery 2008
The Molecular Basis of Cancer
A Bafico, L Grumolato, SA Aaronson
The Molecular Basis of Cancer 2008
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis
MN Nikiforova, YE Nikiforov
Expert Review of Molecular Diagnostics 2008
Intragenic Mutations in Thyroid Cancer
M Sobrinho-Simões, V Máximo, AS Rocha, V Trovisco, P Castro, A Preto, J Lima, P Soares
Endocrinology & Metabolism Clinics of North America 2008
Cancers anaplasiques de la thyroïde
JL Wemeau, CD Cao
Annales d'Endocrinologie 2008
Clinical Impact of Molecular Analysis on Thyroid Cancer Management
VB Wreesmann, B Singh
Surgical oncology clinics of North America 2008
Thyroid adenomatous nodule with bizarre nuclei: A case report and mutation analysis of the p53 gene
K Sato, Y Shimode, M Hirokawa, Y Ueda, S Katsuda
Pathology - Research and Practice 2008
Application of Immunohistochemistry to Thyroid Neoplasms
S Fischer, SL Asa
Archives of pathology & laboratory medicine 2008
Transcriptional Profile of Ki-Ras-Induced Transformation of Thyroid Cells
R Visconti, A Federico, V Coppola, F Pentimalli, MT Berlingieri, P Pallante, M Kruhoffer, TF Orntoft, A Fusco
Cancer Investigation 2007
Establishment and characterization of cell lines from three human thyroid carcinomas: Responses to all-trans-retinoic acid and mutations in the BRAF gene
CS Koh, JL Ku, SY Park, KH Kim, JS Choi, IJ Kim, JH Park, SK Oh, JK Chung, JH Lee, WH Kim, CW Kim, BY Cho, JG Park
Molecular and Cellular Endocrinology 2007
Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma
C Zafon, G Obiols, J Castellví, N Tallada, JA Baena, R Simó, J Mesa
Histopathology 2007
Clinical, Histopathological, and Molecular Characteristics of Papillary Thyroid Microcarcinoma
DJ Lim, KH Baek, YS Lee, WC Park, MK Kim, MI Kang, HM Jeon, JM Lee, B Yun-Cha, KW Lee, HY Son, SK Kang
Thyroid 2007
Anaplastic Carcinoma of the Thyroid Arising More Often from Follicular Carcinoma than Papillary Carcinoma
HM Wang, YW Huang, JS Huang, CH Wang, VC Kok, CM Hung, HM Chen, CY Tzen
Annals of Surgical Oncology 2007
RET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy
M Nakashima, N Takamura, H Namba, V Saenko, S Meirmanov, N Matsumoto, T Hayashi, S Maeda, I Sekine
Human Pathology 2007
Molecular and Genotypic Characterization of Human Thyroid Follicular Cell Carcinoma–Derived Cell Lines
AM Meireles, A Preto, AS Rocha, AP Rebocho, V Máximo, I Pereira-Castro, S Moreira, T Feijão, T Botelho, R Marques, V Trovisco, L Cirnes, C Alves, S Velho, P Soares, M Sobrinho-Simões
Thyroid 2007
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas
R Visone, P Pallante, A Vecchione, R Cirombella, M Ferracin, A Ferraro, S Volinia, S Coluzzi, V Leone, E Borbone, CG Liu, F Petrocca, G Troncone, GA Calin, A Scarpa, C Colato, G Tallini, M Santoro, CM Croce, A Fusco
Oncogene 2007
Differentiated thyroid cancer
M Freeby, RJ McConnell
Community Oncology 2007
RET oncogene amplification in thyroid cancer: Correlations with radiation-associated, high-grade malignancy, and genomic instability
M Nakashima, N Takamura, H Namba, VA Saenko, K Suzuki, S Meirmanov, T Hayashi, I Sekine
International Congress Series 2007
Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis
T Karlidag, B Cobanoglu, E Keles, HC Alpay, I Ozercan, I Kaygusuz, S Yalcin, O Sakallioglu
American Journal of Otolaryngology 2007
Molecular Pathology in Clinical Practice
DG Leonard, A Bagg, AM Caliendo, KL Kaul, VM Deerlin
2007
Surgery of the Thyroid and Parathyroid Glands
D Oertli, R Udelsman
2007
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
T Kondo, S Ezzat, SL Asa
Nature Reviews Cancer 2006
Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions
K Pavelić, RA Dedivitis, S Kapitanović, T Čačev, CR Guirado, D Danić, S Radošević, K Brkić, B Pegan, Š Križanac, Z Kusić, Š Spaventi, M Bura
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2006
Poorly Differentiated Follicular Thyroid Carcinoma Expressing p53 and Presenting as Metastases Only to the Brain
TW Furlanetto, MR Cerski, A Schmidt, AP Paludo, AA Rosa
The Endocrinologist 2006
Pathology and genetics of thyroid carcinoma
RA DeLellis
Journal of Surgical Oncology 2006
2-Methoxyestradiol Induces Apoptosis in Cultured Human Anaplastic Thyroid Carcinoma Cells
P Roswall, S Bu, K Rubin, M Landström, NE Heldin
Thyroid 2006
Genetic Considerations in Thyroid Cancer
KN Patel, B Singh
Cancer control : journal of the Moffitt Cancer Center 2006
Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas
D Corapcioglu, SD Sak, T Delibasi, V Tonyukuk, N Kamel, AR Uysal, S Kocak, S Aydintug, G Erdogan
Journal of Translational Medicine 2006
Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis
TJ Giordano, R Kuick, DG Thomas, DE Misek, M Vinco, D Sanders, Z Zhu, R Ciampi, M Roh, K Shedden, P Gauger, G Doherty, NW Thompson, S Hanash, RJ Koenig, YE Nikiforov
Oncogene 2005
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas
P Pallante, MT Berlingieri, G Troncone, M Kruhoffer, TF Orntoft, G Viglietto, A Caleo, I Migliaccio, M Decaussin-Petrucci, M Santoro, L Palombini, A Fusco
British Journal of Cancer 2005
Immunohistochemical Characterization of Parafollicular Cell Adenoma, Medullary Carcinoma and Follicular Adenocarcinoma in Thyroid of Horses
T OYAMADA, H UEKI, H KOWATARI, P CHUN-HO, Y KATAYAMA, M OIKAWA, H YOSHIKAWA
Journal of Equine Science 2005
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due toBRAF andp53 mutations
RM Quiros, HG Ding, P Gattuso, RA Prinz, X Xu
Cancer 2005
Anaplastic thyroid cancer and hyperthyroidism
Vijay Kumar, Bruno Blanchon, Xin Gu, Marjorie Fowler, David Scarborough, Cherie Ann Nathan, Subhashini Yaturu
Endocrine Pathology 2005
Molecular Carcinogenesis and the Molecular Biology of Human Cancer: Molecular Biology and Clinical Aspects
J Lillehaug, JE Varhaug, Ø Fluge
Molecular Carcinogenesis and the Molecular Biology of Human Cancer: Molecular Biology and Clinical Aspects 2005
Molecular Basis of Thyroid Cancer
NR Farid
2005
Mitogenic Effects of the Up-Regulation of Minichromosome Maintenance Proteins in Anaplastic Thyroid Carcinoma
T Guida, G Salvatore, P Faviana, R Giannini, G Garcia-Rostan, L Provitera, F Basolo, A Fusco, F Carlomagno, M Santoro
The Journal of clinical endocrinology and metabolism 2005
Gene therapy for thyroid cancer
L Barzon, M Pacenti, M Boscaro, G Palù
Expert Opinion on Biological Therapy 2004
BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment
S Begum, E Rosenbaum, R Henrique, Y Cohen, D Sidransky, WH Westra
Modern Pathology 2004
Epithelioid haemangiosarcoma of the thyroid gland. Report of six cases from a non-Alpine region
A Ryska, M Ludvikova, P Szepe, A Boor
Histopathology 2004
Anaplastic Thyroid Carcinoma with Humoral Hypercalcemia of Malignancy (HHM): An Autopsy Case Report
H IWAI, Y OHNO, N AOKI
Endocrine Journal 2004
Implications of Prognostic Factors and Risk Groups in the Management of Differentiated Thyroid Cancer:
AR Shaha
The Laryngoscope 2004
BRAF alterations are associated with complex mutational profiles in malignant melanoma
M Daniotti, M Oggionni, T Ranzani, V Vallacchi, V Campi, DD Stasi, GD Torre, F Perrone, C Luoni, S Suardi, M Frattini, S Pilotti, A Anichini, G Tragni, G Parmiani, MA Pierotti, M Rodolfo
Oncogene 2004
Practical Markers Used in the Diagnosis of Endocrine Tumors:
LA Erickson, RV Lloyd
Advances in Anatomic Pathology 2004
Genetic Alterations Involved in the Transition from Well-Differentiated to Poorly Differentiated and Anaplastic Thyroid Carcinomas
YE Nikiforov
Endocrine Pathology 2004
Definition of Poorly Differentiated Carcinoma of the Thyroid: The Japanese Experience
A Sakamoto
Endocrine Pathology 2004
Cyclooxygenase-2 expression in thyroid neoplasms
Y Ito, H Yoshida, K Nakano, Y Takamura, A Miya, K Kobayashi, T Yokozawa, F Matsuzuka, N Matsuura, K Kuma, A Miyauchi
Histopathology 2003
Anaplastic transformation of thyroid cancer: Review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy
SM Wiseman, TR Loree, NR Rigual, WL Hicks, WG Douglas, GR Anderson, DL Stoler
Head & Neck 2003
Expression of RET in follicular cell-derived tumors of the thyroid gland: Prevalence and implication of morphological type
M Inaba, S Umemura, H Satoh, Y Abe, K Kurokawa, H Sakai, RY Osamura
Pathology International 2003
Is atypical follicular adenoma of the thyroid a preinvasive malignancy?
CY Tzen, YW Huang, YS Fu
Human Pathology 2003
Endocrine Surgery
P Hellman
Endocrine Surgery: Its Physiology and Function 2003
Hypermethylation of the CDKN2/p16INK4A Promotor in Thyroid Carcinogenesis
C Boltze, S Zack, C Quednow, S Bettge, A Roessner, R Schneider-Stock
Pathology - Research and Practice 2003
KAI1 Expression in Thyroid Neoplasms: Its Linkage with Clinicopathologic Features in Papillary Carcinoma
Y Ito, H Yoshida, T Uruno, K Nakano, Y Takamura, A Miya, K Kobayashi, T Yokozawa, F Matsuzuka, K Kuma, A Miyauchi
Pathology - Research and Practice 2003
Surgical Oncology
TJ Saclarides, KW Millikan, CV Godellas
Surgical Oncology 2003
TP53 , p14ARF , p16INK4a and H- ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses: TP53 , p14ARF and p16INK4a Deregulation in ITAC
F Perrone, M Oggionni, S Birindelli, S Suardi, S Tabano, R Romano, ML Moiraghi, G Bimbi, P Quattrone, G Cantu, MA Pierotti, L Licitra, S Pilotti
International Journal of Cancer 2003
Clinical Significance of Molecular Expression Profiles of Hürthle Cell Tumors of the Thyroid Gland Analyzed via Tissue Microarrays
A Hoos, A Stojadinovic, B Singh, ME Dudas, DH Leung, AR Shaha, JP Shah, MF Brennan, C Cordon-Cardo, R Ghossein
The American Journal of Pathology 2002
Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours
BR Haugen, WW Woodmansee, MT McDermott
Clinical Endocrinology 2002
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
V Zuco, R Supino, SC Righetti, L Cleris, E Marchesi, C Gambacorti-Passerini, F Formelli
Cancer Letters 2002
Apoptosis: Life Through Planned Cellular Death Regulating Mechanisms, Control Systems, and Relations with Thyroid Diseases
F Lumachi, S Basso
Thyroid 2002
Genome-wide appraisal of thyroid cancer progression
VB Wreesmann, RA Ghossein, SG Patel, CP Harris, EA Schnaser, AR Shaha, RM Tuttle, JP Shah, PH Rao, B Singh
The American Journal of Pathology 2002
P63 Expression in Papillary and Anaplastic Carcinomas of the Thyroid Gland: Lack of an Oncogenetic Role in Tumorigenesis and Progression
A Preto, JS Reis-Filho, S Ricardo, P Soares
Pathology - Research and Practice 2002
Differential interaction of Enigma protein with the two RET isoforms
MG Borrello, E Mercalli, C Perego, D Degl'Innocenti, S Ghizzoni, E Arighi, B Eroini, MG Rizzetti, MA Pierotti
Biochemical and Biophysical Research Communications 2002
Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway in human anaplastic thyroid cancer cells
Sung Hwa Chung, Naoyoshi Onoda, Tetsuro Ishikawa, Kana Ogisawa, Chiemi Takenaka, Yoshihisa Yano, Fumihiko Hato, Kosei Hirakawa
Japanese journal of cancer research : Gann 2002
ONYX-015, an E1B Gene-Defective Adenovirus, Induces Cell Death in Human Anaplastic Thyroid Carcinoma Cell Lines
G Portella, S Scala, D Vitagliano, G Vecchio, A Fusco
The Journal of clinical endocrinology and metabolism 2002
Molecular Pathobiology of Thyroid Neoplasms
G Tallini
Endocrine Pathology 2002
Peroxisome Proliferator‐activated Receptor Gamma Activation Induces Cell Cycle Arrest via the p53‐independent Pathway in Human Anaplastic Thyroid Cancer Cells
Chung SH, Onoda N, Ishikawa T, Ogisawa K, Takenaka C, Yano Y, Hato F, Hirakawa K
Japanese journal of cancer research : Gann 2002
Bax expression in benign and malignant thyroid tumours: Dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma
S Hermann, I Sturm, A Mrozek, B Klosterhalfen, S Hauptmann, B D�rken, PT Daniel
International Journal of Cancer 2001
Solid Variant of Papillary Thyroid Carcinoma
YE Nikiforov, LA Erickson, MN Nikiforova, CM Caudill, RV Lloyd
The American Journal of Surgical Pathology 2001
GENETIC MARKERS IN THYROID NEOPLASIA
E Puxeddu, JA Fagin
Endocrinology & Metabolism Clinics of North America 2001
Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: Correlations with clinicopathologic features
S Horie, H Maeta, K Endo, T Ueta, K Takashima, T Terada
Pathology International 2001
Thyroid cancer
O Gimm
Cancer Letters 2001
Rb and TP53 Pathway Alterations in Sporadic and NF1-Related Malignant Peripheral Nerve Sheath Tumors
S Birindelli, F Perrone, M Oggionni, C Lavarino, B Pasini, B Vergani, GN Ranzani, MA Pierotti, S Pilotti
Laboratory Investigation 2001
P53 mutations in thyroid carcinoma: Tidings from an old foe
NR Farid
Journal of Endocrinological Investigation 2001
Thyroid Carcinoma Is Characterized by Genomic Instability: Evidence from p53 Mutations
B Shahedian, Y Shi, M Zou, NR Farid
Molecular Genetics and Metabolism 2001
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation
GD Torre, B Pasini, S Frigerio, R Donghi, D Rovini, D Delia, G Peters, TJ Huot, G Bianchi-Scarra, F Lantieri, M Rodolfo, G Parmiani, MA Pierotti
British Journal of Cancer 2001
Paucicellular Variant of Anaplastic Thyroid Carcinoma: Report of Two Cases
JC Canos, A Serrano, X Matias-Guiu
Endocrine Pathology 2001
The likely transformation of papillary thyroid carcinoma into anaplastic carcinoma during postoperative radioactive iodine-131 therapy: Report of a case
K Shingu, S Kobayashi, S Yokoyama, M Fujimori, K Asanuma, K Ito, Y Hama, M Maruyama, R Kusama, J Amano
Surgery Today 2000
Allelotyping of anaplastic thyroid carcinoma: Frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q
Y Kitamura, K Shimizu, S Tanaka, K Ito, M Emi
Genes, Chromosomes and Cancer 2000
Loss of p53 Promotes Anaplasia and Local Invasion in ret/PTC1-Induced Thyroid Carcinomas
KM la Perle, SM Jhiang, CC Capen
The American Journal of Pathology 2000
Oncogenes and Thyroid Cancer
G Vecchio, M Santoro
Clinical Chemistry and Laboratory Medicine 2000
Insular and Anaplastic Carcinoma of the Thyroid
K Lam, C Lo, K Chan, K Wan
Annals of Surgery 2000
Anaplastic Changes Associated with p53 Gene Mutation in Differentiated Thyroid Carcinoma After Insufficient Radioactive Iodine (131I) Therapy
N Sera, K Ashizawa, T Ando, A Ide, Y Abe, T Usa, T Tominaga, E Ejima, T Hayashi, I Shimokawa, K Eguchi
Thyroid 2000
Molecular Alterations Involving p53 Codons 167 and 183 in Papillary Thyroid Carcinomas from Chernobyl-Contaminated Regions of Belarus
AV Pisarchik, G Ermak, NA Kartel, J Figge
Thyroid 2000
In SituApoptosis in the Thyroid
TT Sreelekha, VM Pradeep, K Vijayalakshmi, A Belthazar, VG Chellam, MB Nair, MR Pillai
Thyroid 2000
Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21
KY Lam, CY Lo, KW Chan, KY Wan
Annals of Surgery 2000
Detection of Numerical Chromosome Anomalies in Interphase Cells of Benign and Malignant Thyroid Lesions Using Fluorescence In Situ Hybridization
N Barril, AB Carvalho-Sales, EH Tajara
Cancer Genetics and Cytogenetics 2000
Molecular pathogenesis of thyroid nodules and cancer
F Moretti, S Nanni, A Pontecorvi
Best Practice & Research Clinical Endocrinology & Metabolism 2000
Evaluation of Endocrine Neoplasms Using Fine Needle Aspiration Biopsy
ME Barcus, CN Powers
Endocrine Pathology 2000
Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects
N J Sarlis
Reviews in Endocrine and Metabolic Disorders 2000
Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with Clinical Pathological Features
G Bunone, P Vigneri, L Mariani, S Butó, P Collini, S Pilotti, MA Pierotti, I Bongarzone
The American Journal of Pathology 1999
Advances in the pathogenesis and treatment of thyroid cancer
NN Hanna, PC McGrath, DA Sloan, DE Kenady
Current Opinion in Oncology 1999
p53 mutations in tumors derived from irradiated human thyroid epithelial cells
SC Gamble, MC Cook, AC Riches, Z Herceg, PE Bryant, JE Arrand
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1999
Mutations of p53 in Thyroid Carcinoma with an Insular Component
Y Takeuchi, T Daa, K Kashima, S Yokoyama, I Nakayama, S Noguchi
Thyroid 1999
Immunoreactivity of p53, Ki-67, and Bcl-2 in oncocytic adenomas and carcinomas of the thyroid gland
J Müller-Höcker
Human Pathology 1999
Aspectos moleculares do câncer tiroideano
N Barril, EH Tajara
Arquivos brasileiros de endocrinologia e metabologia 1999
Genetic analysis and clinical application in polygenic diseases. Genetic alterations in thyroid carcinomas
Y Kitamura, K Shimizu, S Tanaka, M Emi
Nippon Ika Daigaku Zasshi 1999
Molecular and Cellular Pediatric Endocrinology
S Handwerger
1999
Apoptosis in thyroid neoplasms: relationship with p53 and bcl-2 expression
Moore, Ohene-Fianko, Garcia, Chakrabarti
Histopathology 1998
Well-differentiated thyroid carcinomas: p53 mutation status and microvessel density
JD Goldenberg, LG Portugal, BL Wenig, K Ferrer, JC Wu, J Sabnani
Head & Neck 1998
Radioiodine-induced thyroid cancer: Studies in the aftermath of the accident at Chernobyl
J Robbins, AB Schneider
Trends in Endocrinology & Metabolism 1998
Prognostic Factors in Papillary and Follicular Thyroid Carcinomas
C Godballe, P Asschenfeldt, KE Jørgensen, L Bastholt, PP Clausen, TP Hansen, O Hansen, SM Bentzen
The Laryngoscope 1998
Transforming Growth Factor-β1 Resistance in a Thyroid Cancer Model of Tumor Necrosis Factor-α Resistance
XP Pang, JM Hershman
Thyroid 1998
Expression of BCL-2 and p53 in oncocytic (Hürthle cell) tumors of the thyroid: An immunohistochemical study
A Kohli, SP Baker, NA Patwardhan, A Khan
Endocrine Pathology 1998
THYROID CANCER: PREDISPOSING CONDITIONS, GROWTH FACTORS, SIGNAL TRANSDUCTION AND ONCOGENES
OH Clark
ANZ Journal of Surgery 1998
Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage
R Lupetti, P Pisarra, A Verrecchia, C Farina, G Nicolini, A Anichini, C Bordignon, M Sensi, G Parmiani, C Traversari
Journal of Experimental Medicine 1998
Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma
C Lavarino, V Corletto, A Mezzelani, GD Torre, C Bartoli, C Riva, MA Pierotti, F Rilke, S Pilotti
British Journal of Cancer 1998
Limited Role of TP53 and TP53-Related Genes in Myxoid Liposarcoma
S Pilotti, C Lavarino, A Mezzelani, GD Torre, F Minoletti, G Sozzi, A Azzarelli, F Rilke, MA Pierotti
TUMORI 1998
Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas
R Elisei, M Shiohara, HP Koeffler, JA Fagin
Cancer 1998
Effects of p53-Expressing Adenovirus on the Chemosensitivity and Differentiation of Anaplastic Thyroid Cancer Cells
MV Blagosklonny, P Giannakakou, M Wojtowicz, LY Romanova, KB Ain, SE Bates, T Fojo
The Journal of clinical endocrinology and metabolism 1998
Immunohistochemical localization of p53 in human thyroid neoplasms: Correlation with biological behavior
SA Hosal, RL Apel, JL Freeman, A Azadian, IB Rosen, VA LiVolsi, SL Asa
Endocrine Pathology 1997
DISTINCT mdm2/p53 EXPRESSION PATTERNS IN LIPOSARCOMA SUBGROUPS: IMPLICATIONS FOR DIFFERENT PATHOGENETIC MECHANISMS
S Pilotti, GD Torre, C Lavarino, SD Palma, G Sozzi, F Minoletti, S Rao, G Pasquini, A Azzarelli, F Rilke, MA Pierotti
The Journal of Pathology 1997
Detection of p53 point mutations by double-gradient, denaturing gradient gel electrophoresis
C Gelfi, SC Righetti, F Zunino, GD Torre, MA Pierotti, PG Righetti
Electrophoresis 1997
Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes
V Pensotti, P Radice, S Presciuttini, D Calistri, I Gazzoli, AP Perez, P Mondini, G Buonsanti, P Sala, C Rossetti, GN Ranzani, L Bertario, MA Pierotti
Genes, Chromosomes and Cancer 1997
No association between immunohistochemical expression of p53, c-erbB-2, Ki-67, estrogen and progesterone receptors in female papillary thyroid cancer and ionizing radiation
MG Karlsson, L Hardell, A Hallquist
Cancer Letters 1997
Involvement of p53 in cell differentiation and development
N Almog, V Rotter
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1997
p53 gene mutations in soft-tissue sarcomas-correlations with p53 immunohistochemistry and DNA ploidy
R Schneider-Stock, K Radig, Y Oda, W Mellin, J Rys, A Niezabitowski, A Roessner
Journal of Cancer Research and Clinical Oncology 1997
Thyroid Pathology
KW Schmid, W Böcker
1997
Possible relation of p53 and mdm-2 oncoprotein expression in thyroid carcinoma: A molecular-pathological and immunohistochemical study on paraffin-embedded tissue
KW Schmid, A Bankfalvi, S Mücke, D Öfner, K Riehemann, S Schröder, A Stücker, M Tötsch, B Dockhorn-Dworniczak
Endocrine Pathology 1996
Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells
MA Pierotti, I Bongarzone, MG Borrello, A Greco, S Pilotti, G Sozzi
Genes, Chromosomes and Cancer 1996
Lack of p16/CDKN2 alterations in thyroid carcinomas
K Yane, N Konishi, Y Kitahori, H Naito, K Okaichi, T Ohnishi, H Miyahara, T Matsunaga, Y Hiasa
Cancer Letters 1996
A frequent mutation/polymorphism in tumor suppressor gene INK4B (MTS-2) in papillary and medullary thyroid cancer
PE Goretzki, V Gorelov, C Dotzenrath, J Witte, HD Roeher
Surgery 1996
Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer
T Nishida, K Nakao, M Hamaji, M Nakahara, M Tsujimoto
Surgery 1996
High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines
CJ Jones, JJ Shaw, FS Wyllie, N Gaillard, M Schlumberger, D Wynford-Thomas
Molecular and Cellular Endocrinology 1996
Loss of responsiveness to transforming growth factor β (TGFβ) is tightly linked to tumorigenicity in a model of thyroid tumour progression
JP Blaydes, D Wynford-Thomas
International Journal of Cancer 1996
Poorly differentiated carcinomas of the thyroid
M Sobrinho-Simões
Endocrine Pathology 1996
p53 gene mutation in thyroid carcinoma
YS Ho, SC Tseng, TY Chin, LL Hsieh, JD Lin
Cancer Letters 1996
Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues
Y Ito, T Kobayashi, T Takeda, Y Komoike, E Wakasugi, Y Tamaki, M Tsujimoto, N Matsuura, M Monden
British Journal of Cancer 1996
p53 in a Thyroid Follicular Carcinoma with Foci of Poorly Differentiated and Anaplastic Carcinoma
X Matias-Guiu, A Villanueva, M Cuatrecasas, G Capella, A De_leiva, J Prat
Pathology - Research and Practice 1996
Critical Commentary
HR Harach
Pathology - Research and Practice 1996
P53 overexpression in head and neck carcinoma and radiotherapy results
S Awwad, E Jaros, J Somes, J Lunec
International journal of radiation oncology, biology, physics 1996
Alterations of p53 and Expression of WAF1/p21 in Human Thyroid Tumors
J Zedenius, C Larsson, G Wallin, M Bäckdahl, U Aspenblad, A Höög, AL Børresen, G Auer
Thyroid 1996
Does telomere shortening drive selection forp53 mutation in human cancer?
E Bresnick, NH Colburn, H Moses, D Wynford-Thomas, JA Bond, FS Wyllie, CJ Jones
Molecular Carcinogenesis 1995
Recent Advances in Cytometry, Cytogenetics and Molecular Genetics of Thyroid Tumours and Tumour-like Lesions
P Soares, M Sobrinho-Simões
Pathology - Research and Practice 1995
Evaluation and Management of the Solid Thyroid Nodule
HB Burch
Endocrinology and metabolism clinics of North America 1995
Allelotyping of follicular thyroid tumors
J Zedenius, G Wallin, A Svensson, L Grimelius, A Hg, G Lundell, M Bckdahl, C Larsson
Human Genetics 1995
Genetics of Follicular Thyroid Cancer
NR Farid, M Zou, Y Shi
Endocrinology and metabolism clinics of North America 1995
Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas
L Papi, LR Vitis, F Vitelli, E Montali, U Bigozzi, F Ammannati, P Mennonna
Human Genetics 1995
Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland
R Holm, JM Nesland
The Journal of Pathology 1994
p53 Protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland
W Czyz, H Joensuu, L Pylkkänen, PJ Klemi
The Journal of Pathology 1994
Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland
S Pilotti, P Collini, F Rilke, G Cattoretti, RD Bo, MA Pierotti
The Journal of Pathology 1994
Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid
P Soares, J Cameselle-Teijeiro, M Sobrinho-Simões
Histopathology 1994
Analysis of adenomatous polyposis coli gene in thyroid tumours
G Colletta, S Sciacchitano, R Palmirotta, A Ranieri, E Zanella, A Cama, RM Costantini, P Battista, A Pontecorvi
British Journal of Cancer 1994
Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas
G Manenti, S Pilotti, FC Re, GD Porta, MA Pierotti
European Journal of Cancer 1994
Absence of p53 mutation in Japanese patients with malignant thyroid lymphoma
K Iyota, K Takeda, F Matsuzuka, T Okabayashi, S Morita, K Kuma, K Hashimoto
Journal of Endocrinological Investigation 1994
p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas
X Matias-Guiu, M Cuatrecasas, E Musulen, J Prat
Journal of clinical pathology 1994
Nongenotoxic Carcinogenesis
A Cockburn, L Smith
1994
Invited commentary
PJ Kozinn
World Journal of Surgery 1980

← Previous 1 2 3 4 … 10 11 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Referenced in 2 patents
Referenced in 1 clinical guideline sources
58 readers on Mendeley
See more details